查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1860009

海洋製药：全球市场份额和排名、总收入和需求预测（2025-2031年）

Marine Pharmaceuticals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 105 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球海洋医药市场规模估计为346.9亿美元，预计到2031年将达到609.2亿美元，2025年至2031年的复合年增长率为8.5%。

传统上，鲨鱼油、鳕鱼肝油、海藻酸钠、琼脂和几丁质等海洋生物来源药物是潜在的药物研发资源。生命起源于海洋，海洋覆盖了地球表面70%以上的面积，孕育从微生物到脊椎动物的高度生态学、化学和生物多样性。这种多样性蕴藏着丰富的独特化合物，具有巨大的药用潜力。本报告探讨了海洋来源的药物和膳食补充剂。

海洋药物是指生物来源（如海绵、海藻、软体动物和深海微生物）的具有药理活性的天然产物，包括小分子药物、蛋白质、Glico等。这些药物具有独特的结构和生物活性，广泛用于治疗癌症、病毒感染疾病、发炎等疾病。随着海洋生物多样性研究的深入，海洋药物作为新药研发的重要方向，正日益受到关注。

海洋製药产业目前正处于快速发展阶段，这背后有许多因素。首先，全球对新药的需求不断增长，尤其是在癌症、病毒感染疾病和发炎等领域，而海洋药物因其独特的生物活性而成为研究热点。其次，基因组学、蛋白质组学和高通量筛检等技术的进步为海洋药物的发现和开发提供了强有力的支持。此外，各国政府和企业对海洋药物研发的持续投入也加速了产业的发展。

儘管海洋製药产业前景广阔，但也面临许多挑战与风险。首先，海洋製药研发週期长、高成本，且临床应用率低，限制了产业化进程。其次，海洋资源的开采受到环保政策的限制，导致资源供应不稳定。此外，海洋製药的生产流程复杂，大规模生产面临技术和成本的双重挑战。

海洋来源药物的需求主要集中在製药、保健品和化妆品产业。随着人们健康意识的不断提高，对天然药物和功能性保健品的需求持续增长。海洋来源药物因其独特的疗效而备受关注，尤其是在治疗癌症和自体免疫疾病等慢性疾病方面。同时，随着人口老化，具有抗衰老和抗炎特性的海洋来源药物的市场需求也在上升。

海洋药材上游资源主要包括海洋生物资源及相关生物技术支援。海洋生物资源的丰富多样性为海洋药材的研发提供了充足的原料，但海洋资源的永续取得和保护已成为重要的挑战。同时，基因编辑、合成生物学等生物技术的进步为海洋药材的高效生产开闢了新的途径。

本报告旨在对全球海洋药物市场进行全面分析，重点关注总收入、市场份额和主要企业的排名，以及按地区/国家、类型和应用对海洋药物进行分析。

本报告以销售收入为指标，对海洋製药市场规模、估计值和预测进行了呈现，以 2024 年为基准年，并涵盖了 2020 年至 2031 年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，旨在帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就海洋製药领域做出明智的商业决策。

市场区隔

公司

  • Seattle Genetics
  • DSM
  • Eisai Co
  • Takeda
  • BASF
  • Amway
  • Pfizer
  • Pelagia（EPAX）
  • Pharma Mar
  • Croda
  • GNC
  • GSK
  • TerSera Therapeutics
  • Nordic Naturals
  • Carlson Labs

按类型分類的细分市场

  • 製药
  • 保健品

应用领域

  • 医院和诊所
  • 药局
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Marine Pharmaceuticals was estimated to be worth US$ 34690 million in 2024 and is forecast to a readjusted size of US$ 60920 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.

The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc. Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential. In our report, we study the drugs and health supplement from marine.

Marine pharmaceuticals refer to natural products with pharmacological activity derived from marine organisms, including small molecule drugs, proteins, glycosaminoglycans, and other forms. These drugs are sourced from marine organisms such as sponges, seaweeds, mollusks, and deep-sea microorganisms, possessing unique structures and biological activities, often used in the treatment of cancer, viral infections, inflammation, and other conditions. With the advancement of marine biodiversity research, marine pharmaceuticals have gradually become a significant focus in new drug development.

The marine pharmaceutical industry is in a phase of rapid development, driven by several factors. Firstly, there is an increasing global demand for new drugs, especially in areas like cancer, viral infections, and inflammation, making marine pharmaceuticals a research hotspot due to their unique biological activities. Secondly, advancements in technologies such as genomics, proteomics, and high-throughput screening have provided strong support for the discovery and development of marine drugs. Additionally, continuous investment from governments and enterprises in marine pharmaceutical research and development is accelerating industry growth.

Despite the promising prospects of the marine pharmaceutical industry, it faces several challenges and risks. Firstly, the research and development cycle for marine drugs is long, costly, and has a low clinical conversion rate, leading to a slow industrialization process. Secondly, the acquisition of marine resources is restricted by environmental protection policies, resulting in unstable resource supply. Moreover, the production processes for marine drugs are complex, and large-scale manufacturing faces both technical and cost pressures.

The downstream demand for marine pharmaceuticals is primarily concentrated in the pharmaceutical, health supplement, and cosmetics industries. With increasing public awareness of health, the demand for natural medicines and functional health products continues to grow. Marine pharmaceuticals, especially in the treatment of chronic diseases such as cancer and autoimmune disorders, are gaining attention due to their unique efficacy. Simultaneously, with the advent of an aging society, the market demand for anti-aging and anti-inflammatory marine drugs is also on the rise.

The upstream raw materials for marine pharmaceuticals mainly include marine biological resources and related biotechnological support. The diversity of marine biological resources provides abundant materials for the development of marine drugs. However, the sustainable acquisition and protection of marine resources have become critical issues. At the same time, advancements in biotechnology, such as gene editing and synthetic biology, offer new pathways for the efficient production of marine pharmaceuticals.

This report aims to provide a comprehensive presentation of the global market for Marine Pharmaceuticals, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Marine Pharmaceuticals by region & country, by Type, and by Application.

The Marine Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Pharmaceuticals.

Market Segmentation

By Company

  • Seattle Genetics
  • DSM
  • Eisai Co
  • Takeda
  • BASF
  • Amway
  • Pfizer
  • Pelagia (EPAX)
  • Pharma Mar
  • Croda
  • GNC
  • GSK
  • TerSera Therapeutics
  • Nordic Naturals
  • Carlson Labs

Segment by Type

  • Drugs
  • Health Supplement

Segment by Application

  • Hospital & Clinic
  • Pharmacy
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Marine Pharmaceuticals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Marine Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Marine Pharmaceuticals in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Marine Pharmaceuticals Product Introduction
  • 1.2 Global Marine Pharmaceuticals Market Size Forecast (2020-2031)
  • 1.3 Marine Pharmaceuticals Market Trends & Drivers
    • 1.3.1 Marine Pharmaceuticals Industry Trends
    • 1.3.2 Marine Pharmaceuticals Market Drivers & Opportunity
    • 1.3.3 Marine Pharmaceuticals Market Challenges
    • 1.3.4 Marine Pharmaceuticals Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Marine Pharmaceuticals Players Revenue Ranking (2024)
  • 2.2 Global Marine Pharmaceuticals Revenue by Company (2020-2025)
  • 2.3 Key Companies Marine Pharmaceuticals Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Marine Pharmaceuticals Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Marine Pharmaceuticals
  • 2.6 Marine Pharmaceuticals Market Competitive Analysis
    • 2.6.1 Marine Pharmaceuticals Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Marine Pharmaceuticals Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Pharmaceuticals as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Drugs
    • 3.1.2 Health Supplement
  • 3.2 Global Marine Pharmaceuticals Sales Value by Type
    • 3.2.1 Global Marine Pharmaceuticals Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Marine Pharmaceuticals Sales Value, by Type (2020-2031)
    • 3.2.3 Global Marine Pharmaceuticals Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital & Clinic
    • 4.1.2 Pharmacy
    • 4.1.3 Other
  • 4.2 Global Marine Pharmaceuticals Sales Value by Application
    • 4.2.1 Global Marine Pharmaceuticals Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Marine Pharmaceuticals Sales Value, by Application (2020-2031)
    • 4.2.3 Global Marine Pharmaceuticals Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Marine Pharmaceuticals Sales Value by Region
    • 5.1.1 Global Marine Pharmaceuticals Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Marine Pharmaceuticals Sales Value by Region (2020-2025)
    • 5.1.3 Global Marine Pharmaceuticals Sales Value by Region (2026-2031)
    • 5.1.4 Global Marine Pharmaceuticals Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Marine Pharmaceuticals Sales Value, 2020-2031
    • 5.2.2 North America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Marine Pharmaceuticals Sales Value, 2020-2031
    • 5.3.2 Europe Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Marine Pharmaceuticals Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Marine Pharmaceuticals Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Marine Pharmaceuticals Sales Value, 2020-2031
    • 5.5.2 South America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Marine Pharmaceuticals Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Marine Pharmaceuticals Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Marine Pharmaceuticals Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.3.2 United States Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.4.2 Europe Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.5.2 China Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.6.2 Japan Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.7.2 South Korea Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Marine Pharmaceuticals Sales Value, 2020-2031
    • 6.9.2 India Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Seattle Genetics
    • 7.1.1 Seattle Genetics Profile
    • 7.1.2 Seattle Genetics Main Business
    • 7.1.3 Seattle Genetics Marine Pharmaceuticals Products, Services and Solutions
    • 7.1.4 Seattle Genetics Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Seattle Genetics Recent Developments
  • 7.2 DSM
    • 7.2.1 DSM Profile
    • 7.2.2 DSM Main Business
    • 7.2.3 DSM Marine Pharmaceuticals Products, Services and Solutions
    • 7.2.4 DSM Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.2.5 DSM Recent Developments
  • 7.3 Eisai Co
    • 7.3.1 Eisai Co Profile
    • 7.3.2 Eisai Co Main Business
    • 7.3.3 Eisai Co Marine Pharmaceuticals Products, Services and Solutions
    • 7.3.4 Eisai Co Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Eisai Co Recent Developments
  • 7.4 Takeda
    • 7.4.1 Takeda Profile
    • 7.4.2 Takeda Main Business
    • 7.4.3 Takeda Marine Pharmaceuticals Products, Services and Solutions
    • 7.4.4 Takeda Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Takeda Recent Developments
  • 7.5 BASF
    • 7.5.1 BASF Profile
    • 7.5.2 BASF Main Business
    • 7.5.3 BASF Marine Pharmaceuticals Products, Services and Solutions
    • 7.5.4 BASF Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.5.5 BASF Recent Developments
  • 7.6 Amway
    • 7.6.1 Amway Profile
    • 7.6.2 Amway Main Business
    • 7.6.3 Amway Marine Pharmaceuticals Products, Services and Solutions
    • 7.6.4 Amway Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Amway Recent Developments
  • 7.7 Pfizer
    • 7.7.1 Pfizer Profile
    • 7.7.2 Pfizer Main Business
    • 7.7.3 Pfizer Marine Pharmaceuticals Products, Services and Solutions
    • 7.7.4 Pfizer Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Pfizer Recent Developments
  • 7.8 Pelagia (EPAX)
    • 7.8.1 Pelagia (EPAX) Profile
    • 7.8.2 Pelagia (EPAX) Main Business
    • 7.8.3 Pelagia (EPAX) Marine Pharmaceuticals Products, Services and Solutions
    • 7.8.4 Pelagia (EPAX) Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Pelagia (EPAX) Recent Developments
  • 7.9 Pharma Mar
    • 7.9.1 Pharma Mar Profile
    • 7.9.2 Pharma Mar Main Business
    • 7.9.3 Pharma Mar Marine Pharmaceuticals Products, Services and Solutions
    • 7.9.4 Pharma Mar Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Pharma Mar Recent Developments
  • 7.10 Croda
    • 7.10.1 Croda Profile
    • 7.10.2 Croda Main Business
    • 7.10.3 Croda Marine Pharmaceuticals Products, Services and Solutions
    • 7.10.4 Croda Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Croda Recent Developments
  • 7.11 GNC
    • 7.11.1 GNC Profile
    • 7.11.2 GNC Main Business
    • 7.11.3 GNC Marine Pharmaceuticals Products, Services and Solutions
    • 7.11.4 GNC Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.11.5 GNC Recent Developments
  • 7.12 GSK
    • 7.12.1 GSK Profile
    • 7.12.2 GSK Main Business
    • 7.12.3 GSK Marine Pharmaceuticals Products, Services and Solutions
    • 7.12.4 GSK Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.12.5 GSK Recent Developments
  • 7.13 TerSera Therapeutics
    • 7.13.1 TerSera Therapeutics Profile
    • 7.13.2 TerSera Therapeutics Main Business
    • 7.13.3 TerSera Therapeutics Marine Pharmaceuticals Products, Services and Solutions
    • 7.13.4 TerSera Therapeutics Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.13.5 TerSera Therapeutics Recent Developments
  • 7.14 Nordic Naturals
    • 7.14.1 Nordic Naturals Profile
    • 7.14.2 Nordic Naturals Main Business
    • 7.14.3 Nordic Naturals Marine Pharmaceuticals Products, Services and Solutions
    • 7.14.4 Nordic Naturals Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Nordic Naturals Recent Developments
  • 7.15 Carlson Labs
    • 7.15.1 Carlson Labs Profile
    • 7.15.2 Carlson Labs Main Business
    • 7.15.3 Carlson Labs Marine Pharmaceuticals Products, Services and Solutions
    • 7.15.4 Carlson Labs Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Carlson Labs Recent Developments

8 Industry Chain Analysis

  • 8.1 Marine Pharmaceuticals Industrial Chain
  • 8.2 Marine Pharmaceuticals Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Marine Pharmaceuticals Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Marine Pharmaceuticals Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Marine Pharmaceuticals Market Trends
  • Table 2. Marine Pharmaceuticals Market Drivers & Opportunity
  • Table 3. Marine Pharmaceuticals Market Challenges
  • Table 4. Marine Pharmaceuticals Market Restraints
  • Table 5. Global Marine Pharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Marine Pharmaceuticals Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Marine Pharmaceuticals Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Marine Pharmaceuticals Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Marine Pharmaceuticals
  • Table 10. Global Marine Pharmaceuticals Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Pharmaceuticals as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Marine Pharmaceuticals Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Marine Pharmaceuticals Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Marine Pharmaceuticals Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Marine Pharmaceuticals Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Marine Pharmaceuticals Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Marine Pharmaceuticals Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Marine Pharmaceuticals Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Marine Pharmaceuticals Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Marine Pharmaceuticals Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Marine Pharmaceuticals Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Marine Pharmaceuticals Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Marine Pharmaceuticals Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Marine Pharmaceuticals Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Marine Pharmaceuticals Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Marine Pharmaceuticals Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Marine Pharmaceuticals Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Marine Pharmaceuticals Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Marine Pharmaceuticals Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Seattle Genetics Basic Information List
  • Table 32. Seattle Genetics Description and Business Overview
  • Table 33. Seattle Genetics Marine Pharmaceuticals Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Marine Pharmaceuticals Business of Seattle Genetics (2020-2025)
  • Table 35. Seattle Genetics Recent Developments
  • Table 36. DSM Basic Information List
  • Table 37. DSM Description and Business Overview
  • Table 38. DSM Marine Pharmaceuticals Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Marine Pharmaceuticals Business of DSM (2020-2025)
  • Table 40. DSM Recent Developments
  • Table 41. Eisai Co Basic Information List
  • Table 42. Eisai Co Description and Business Overview
  • Table 43. Eisai Co Marine Pharmaceuticals Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Marine Pharmaceuticals Business of Eisai Co (2020-2025)
  • Table 45. Eisai Co Recent Developments
  • Table 46. Takeda Basic Information List
  • Table 47. Takeda Description and Business Overview
  • Table 48. Takeda Marine Pharmaceuticals Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Marine Pharmaceuticals Business of Takeda (2020-2025)
  • Table 50. Takeda Recent Developments
  • Table 51. BASF Basic Information List
  • Table 52. BASF Description and Business Overview
  • Table 53. BASF Marine Pharmaceuticals Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Marine Pharmaceuticals Business of BASF (2020-2025)
  • Table 55. BASF Recent Developments
  • Table 56. Amway Basic Information List
  • Table 57. Amway Description and Business Overview
  • Table 58. Amway Marine Pharmaceuticals Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Marine Pharmaceuticals Business of Amway (2020-2025)
  • Table 60. Amway Recent Developments
  • Table 61. Pfizer Basic Information List
  • Table 62. Pfizer Description and Business Overview
  • Table 63. Pfizer Marine Pharmaceuticals Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Marine Pharmaceuticals Business of Pfizer (2020-2025)
  • Table 65. Pfizer Recent Developments
  • Table 66. Pelagia (EPAX) Basic Information List
  • Table 67. Pelagia (EPAX) Description and Business Overview
  • Table 68. Pelagia (EPAX) Marine Pharmaceuticals Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Marine Pharmaceuticals Business of Pelagia (EPAX) (2020-2025)
  • Table 70. Pelagia (EPAX) Recent Developments
  • Table 71. Pharma Mar Basic Information List
  • Table 72. Pharma Mar Description and Business Overview
  • Table 73. Pharma Mar Marine Pharmaceuticals Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Marine Pharmaceuticals Business of Pharma Mar (2020-2025)
  • Table 75. Pharma Mar Recent Developments
  • Table 76. Croda Basic Information List
  • Table 77. Croda Description and Business Overview
  • Table 78. Croda Marine Pharmaceuticals Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Marine Pharmaceuticals Business of Croda (2020-2025)
  • Table 80. Croda Recent Developments
  • Table 81. GNC Basic Information List
  • Table 82. GNC Description and Business Overview
  • Table 83. GNC Marine Pharmaceuticals Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Marine Pharmaceuticals Business of GNC (2020-2025)
  • Table 85. GNC Recent Developments
  • Table 86. GSK Basic Information List
  • Table 87. GSK Description and Business Overview
  • Table 88. GSK Marine Pharmaceuticals Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Marine Pharmaceuticals Business of GSK (2020-2025)
  • Table 90. GSK Recent Developments
  • Table 91. TerSera Therapeutics Basic Information List
  • Table 92. TerSera Therapeutics Description and Business Overview
  • Table 93. TerSera Therapeutics Marine Pharmaceuticals Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Marine Pharmaceuticals Business of TerSera Therapeutics (2020-2025)
  • Table 95. TerSera Therapeutics Recent Developments
  • Table 96. Nordic Naturals Basic Information List
  • Table 97. Nordic Naturals Description and Business Overview
  • Table 98. Nordic Naturals Marine Pharmaceuticals Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Marine Pharmaceuticals Business of Nordic Naturals (2020-2025)
  • Table 100. Nordic Naturals Recent Developments
  • Table 101. Carlson Labs Basic Information List
  • Table 102. Carlson Labs Description and Business Overview
  • Table 103. Carlson Labs Marine Pharmaceuticals Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Marine Pharmaceuticals Business of Carlson Labs (2020-2025)
  • Table 105. Carlson Labs Recent Developments
  • Table 106. Key Raw Materials Lists
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Marine Pharmaceuticals Downstream Customers
  • Table 109. Marine Pharmaceuticals Distributors List
  • Table 110. Research Programs/Design for This Report
  • Table 111. Key Data Information from Secondary Sources
  • Table 112. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Marine Pharmaceuticals Product Picture
  • Figure 2. Global Marine Pharmaceuticals Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Marine Pharmaceuticals Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Marine Pharmaceuticals Report Years Considered
  • Figure 5. Global Marine Pharmaceuticals Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Marine Pharmaceuticals Revenue in 2024
  • Figure 7. Marine Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Drugs Picture
  • Figure 9. Health Supplement Picture
  • Figure 10. Global Marine Pharmaceuticals Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Marine Pharmaceuticals Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Hospital & Clinic
  • Figure 13. Product Picture of Pharmacy
  • Figure 14. Product Picture of Other
  • Figure 15. Global Marine Pharmaceuticals Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Marine Pharmaceuticals Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Marine Pharmaceuticals Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Marine Pharmaceuticals Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Marine Pharmaceuticals Sales Value (%), (2020-2031)
  • Figure 28. United States Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Marine Pharmaceuticals Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Marine Pharmaceuticals Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Marine Pharmaceuticals Industrial Chain
  • Figure 50. Marine Pharmaceuticals Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed